INIS
antibodies
100%
patients
100%
receptors
100%
acetylcholine
100%
therapy
75%
spectra
50%
muscles
50%
immunosuppressive drugs
50%
plasma cells
50%
diseases
25%
damage
25%
side effects
25%
reviews
25%
production
25%
membranes
25%
junctions
25%
transmission
25%
immunotherapy
25%
immunosuppression
25%
Keyphrases
Myasthenia Gravis
100%
Acetylcholine Receptor Antibody
100%
Novel Treatments
100%
Related Disorders
100%
Acetylcholine Receptor (AChR)
60%
Autoantibodies
40%
Immunosuppressive Drugs
40%
Autoimmune Disease
20%
Related Conditions
20%
Pharmacological Treatment
20%
Therapeutic Approaches
20%
Patient Selection
20%
Novel Therapeutics
20%
Most Common Cause
20%
Complete Remission
20%
Muscle Weakness
20%
Immunosuppression
20%
Plasma Cells
20%
Targeted Immunotherapy
20%
Neuromuscular Junction
20%
Novel Therapies
20%
Synaptic Transmission
20%
Long-lived Plasma Cells
20%
Muscle Nicotinic Acetylcholine Receptor
20%
Synaptic Membrane
20%
Antibody-mediated Autoimmune Diseases
20%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Myasthenia gravis
100%
Cholinergic Receptor Antibody
100%
Immunosuppressive Agent
40%
Autoimmune Disease
40%
Autoantibodies
40%
Cholinergic Receptor
40%
Side Effect
20%
Remission
20%
Muscle Weakness
20%
Nicotinic Receptor
20%
Immunotherapy
20%
Immunology and Microbiology
Myasthenia gravis
100%
Cholinergic Receptor Antibody
100%
Immunosuppressive Drug
40%
Autoimmune Disease
40%
Autoantibodies
40%
Plasma Cell
40%
Monospecific Antibody
20%
Immunosuppression
20%
Nicotinic Acetylcholine Receptor
20%
Immunotherapy
20%
Neuromuscular Junction
20%
Postsynaptic Membrane
20%
Synaptic Transmission
20%